CAMP4 Therapeutics Corporation

CAMP · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
11/30/2023
2/28/2023
Assets
Cash & Equivalents$64,039$38,380$83,190
Short-Term Investments$0$0$0
Receivables$108$442$678
Inventory$0$0$0
Other Curr. Assets$2,236$1,191$541
Total Curr. Assets$66,383$40,013$84,409
Property Plant & Equip (Net)$10,300$13,309$16,795
Goodwill$0$0$0
Intangibles$0$0$0
Long-Term Investments$0$0$0
Tax Assets$0$0$0
Other NC Assets$1,624$1,624$1,346
Total NC Assets$11,924$14,933$18,141
Other Assets$0$0-$1
Total Assets$78,307$54,946$102,549
Liabilities
Payables$1,210$1,042$2,151
Short-Term Debt$3,085$3,058$2,370
Tax Payable$0$0$0
Deferred Revenue$385$0$0
Other Curr. Liab.$4,918$3,707$3,425
Total Curr. Liab.$9,598$7,807$7,946
LT Debt$5,563$8,635$10,025
Deferred Rev, NC$0$0$0
Deferred Tax Liab, NC$0$0$0
Other NC Liab.$2$162,234$162,109
Total NC Liab.$5,565$170,869$172,134
Other Liabilities$0$0$0
Cap. Leases$8,648$11,693$12,395
Total Liabilities$15,163$178,676$180,080
Equity
Pref Stock$0$0$0
Common Stock$2$1$1
Retained Earnings-$211,753-$159,962-$110,671
AOCI$0$0$0
Other Equity$274,895$36,231$33,139
Total Equity$63,144-$123,730-$77,531
Supplemental Information
Minority Interest$0$0$0
Total Liab. & Tot. Equity$78,307$54,946$102,549
Net Debt-$55,391-$26,687$0-$70,795